Agios Pharmaceuticals | AGIO - رأس المال والاحتياطيات





رأس المال والاحتياطيات تغيير تاريخ
AbbVie USD -6.66B 3.39B 2026-03
Agios Pharmaceuticals USD 1.03B 83.09M 2026-06
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
Amgen USD 9.19B 532M 2026-03
Arrowhead Research USD 613.98M 45.56M 2026-03
Astellas Pharma JPY 1.83T 65.92B 2026-03
AstraZeneca USD 50.3B 2.96B 2026-06
Bayer EUR 28.85B 2.9B 2026-03
Biogen USD 18.85B 196.3M 2026-06
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Daiichi Sankyo JPY 1.7T 38.53B 2026-06
Eli Lilly USD 31.2B 4.66B 2026-03
Exelixis USD 1.94B 225.57M 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
GlaxoSmithKline GBP 17.64B 223M 2026-06
Incyte USD 6.34B 721.58M 2026-06
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
Merck USD 45.88B 6.73B 2026-03
Moderna USD 6.76B 647M 2026-06
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Novartis USD 41.95B 3.02B 2026-06
Novartis USD 38.93B 7.2B 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03